Login / Signup

Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy.

Zahra Jama ShireFrederic ReicherzSally LawrenceHarjeev SudanLiam GoldingAbdelilah MajdoubiPaul N LevettPascal M LavoieKevan Jacobson
Published in: Gut (2021)
Keyphrases
  • patients with inflammatory bowel disease
  • sars cov
  • rheumatoid arthritis
  • intensive care unit
  • respiratory syndrome coronavirus
  • emergency department
  • stem cells
  • newly diagnosed
  • bone marrow
  • replacement therapy